Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )

Clinical trial NCT02899104 · COMPLETED

Trial details

NCT number: NCT02899104
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Neoplasms, Castration-Resistant

Start date: 2017-06-15
Primary completion: 2019-03-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.